Caseware UK (AP4) 2024.0.164 2024.0.164 2025-12-31 2025-12-31 false 2 The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2025-01-01 The principal activity of the Company is to provide data protection compliance services for Healthcare, Pharmaceutical and Healthtech companies.2 true true false 15256972 2025-01-01 2025-12-31 15256972 2023-11-02 2024-12-31 15256972 2025-12-31 15256972 2024-12-31 15256972 c:Director2 2025-01-01 2025-12-31 15256972 d:CurrentFinancialInstruments 2025-12-31 15256972 d:CurrentFinancialInstruments 2024-12-31 15256972 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 15256972 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 15256972 d:ShareCapital 2025-12-31 15256972 d:ShareCapital 2024-12-31 15256972 d:RetainedEarningsAccumulatedLosses 2025-12-31 15256972 d:RetainedEarningsAccumulatedLosses 2024-12-31 15256972 c:OrdinaryShareClass1 2025-01-01 2025-12-31 15256972 c:OrdinaryShareClass1 2025-12-31 15256972 c:OrdinaryShareClass1 2024-12-31 15256972 c:FRS102 2025-01-01 2025-12-31 15256972 c:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 15256972 c:FullAccounts 2025-01-01 2025-12-31 15256972 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 15256972 e:PoundSterling 2025-01-01 2025-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 15256972 ILIOMAD HEALTH DATA UK LIMITED UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
ILIOMAD HEALTH DATA UK LIMITED REGISTERED NUMBER: 15256972 BALANCE SHEET AS AT 31 DECEMBER 2025
|  | 2025 |  | 2024
Note |  | £ |  | £
CURRENT ASSETS |  |  |  |  |
Debtors: amounts falling due within one year | 4 | 4,198 |  | 3,485 |
Cash at bank and in hand |  | 24,732 |  | 6,397 |
|  | 28,930 |  | 9,882 |
Creditors: amounts falling due within one year | 5 | (25,348) |  | (5,255) |
NET CURRENT ASSETS |  |  | 3,582 |  | 4,627
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 3,582 |  | 4,627
NET ASSETS |  |  | 3,582 |  | 4,627
CAPITAL AND RESERVES |  |  |  |  |
Called up share capital | 6 |  | 1 |  | 1
Profit and loss account |  |  | 3,581 |  | 4,626
|  |  | 3,582 |  | 4,627
The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
S Larroque
Director
Date: 9 March 2026
Page 1
ILIOMAD HEALTH DATA UK LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
1. | GENERAL INFORMATION
Iliomad Health Data UK Limited is a private company limited by shares and incorporated in England and Wales. Its registered office address is Salisbury House, Station Road, Cambridge, CB1 2LA. Unless otherwise stated, figures are rounded to the nearest pound (£). 2.ACCOUNTING POLICIES
| 2.1 | BASIS OF PREPARATION OF FINANCIAL STATEMENTS
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The following principal accounting policies have been applied:
| 2.2 | FOREIGN CURRENCY TRANSLATION
Functional and presentation currency The Company's functional and presentational currency is GBP. Transactions and balances Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.
| 2.3 | TURNOVER
Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
| 2.4 | TAXATION
Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income. Page 2
ILIOMAD HEALTH DATA UK LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 2.ACCOUNTING POLICIES (CONTINUED)
| 2.5 | DEBTORS
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 2.6 | CASH AND CASH EQUIVALENTS
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 2.7 | CREDITORS
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
| 2.8 | DIVIDENDS
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.
3. | EMPLOYEES
| The average monthly number of employees, including directors, during the year was 2 (2024 - 2), who received no remuneration.
Page 3
ILIOMAD HEALTH DATA UK LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
4. | DEBTORS
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Trade debtors | 2,912 | 2,309
| Prepayments and accrued income | 1,286 | 1,176
|  | 4,198 | 3,485
5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Amounts owed to group undertakings | 18,319 | 864
| Corporation tax | 3,849 | 1,367
| Accruals and deferred income | 3,180 | 3,024
|  | 25,348 | 5,255
| Amounts owed to group undertakings are unsecured, interest free and repayable on demand.
6. | SHARE CAPITAL
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
|  | ALLOTTED, CALLED UP AND FULLY PAID |  |
|  | 1 (2024 - 1) Ordinary share of £1.00 | 1 | 1
Page 4